Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neuropathic Pain: early-phase trial registry
16 of 36 indexed Neuropathic Pain trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #419 of 28,707 conditions by registered trial count.
36 US clinical trials · 16 currently recruiting · #419 of 28,707 conditions by registered trial count
Neuropathic Pain: 36 US clinical trials tracked, 16 recruiting.
Neuropathic Pain is the subject of 36 registered US clinical trials on ClinicalTrials.gov, 16 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most active sponsor is NeuraLace Medical, running 2 of these trials.
Enrollment posture brief
Registry condition neuropathic-pain
OPEN 16 | RECR 44% | LATE 1 | EARLY 12 | RANK #419 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)
Neuropathic Pain lists 16 open slots (44% of 36 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neuropathic Pain on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neuropathic Pain is recruiting above its size-band peers.
16 of 36 indexed trials (44.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Neuropathic Pain trials is spread across many organizations.
NeuraLace Medical accounts for 2 of 36 trials (5.6%). 29 distinct sponsors appear on at least one study for this condition label.
-
Most Neuropathic Pain trials plan to enrol fewer than 100 people.
Median target enrolment is 38 among the 36 trials that report a genuine target (sentinel values excluded). 27 of those (75%) plan for fewer than 100 participants.
-
Neuropathic Pain research is mostly interventional.
29 interventional and 7 observational studies make up this index (80.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
36 total, page 1 of 1
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain
VA Office of Research and Development
NCT05351801
Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury
Texas A&M University
NCT05005026
The Prevalence of Neuropathic Pain Pathophysiology Associated With Ankle Fracture
Indiana University
NCT06420141
Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy
Virginia Commonwealth University
NCT05259527
Ginger Root Extract for Sciatic Pain Individuals
Leslie Shen
NCT06817018
Virtual Walking Therapy for Neuropathic Pain Following Incomplete Spinal Cord Injury
Texas A&M University
NCT06330181
Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation
Ashwin Viswanathan
NCT05968664
Brain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study
VA Office of Research and Development
NCT05811312
Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury
EicOsis Human Health
NCT06438471
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
Margaux M. Salas, PhD
NCT06414356
Utility of Multisensory Body-Representation in Spinal Cord Injury (SCI) With Pain
University of Miami
NCT06010251
Virtual Reality (VR) Self-Hypnosis Software
Icahn School of Medicine at Mount Sinai
NCT06398847
Diabetic Neuropathy in Spinal Cord Stimulator Patients
University of Chicago
NCT04687215
Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI
University of Miami
NCT05630235
Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI
Medical University of South Carolina
NCT05492188
Insula Neuromodulation for Chronic Neuropathic Pain
University of Virginia
NCT05404581
Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:
InSightec
NCT03100474
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
Eli Lilly and Company
NCT06568042
Biomarkers for Pain in Spinal Cord Injury (SCI) Patients
The University of Texas Health Science Center, Houston
NCT00913471
Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management
NeuraLace Medical
NCT04795635
Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
Wake Forest University Health Sciences
NCT05674240
Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).
Saint Francis Hospital
NCT06246526
Radicle Relief 1: A Study of Health and Wellness Products on Pain and Other Health Outcomes
Radicle Science
NCT05589935
Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain
New York University
NCT03855111
Virtual Walking for Neuropathic Pain in Spinal Cord Injury
University of Alabama at Birmingham
NCT01884662
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)
St. Jude Children's Research Hospital
NCT01506453
BMS-741672 for Diabetic Neuropathic Pain
Bristol-Myers Squibb
NCT00683423
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain
Wake Forest University Health Sciences
NCT04156802
Pain Inflammation and Cannabis in HIV
Montefiore Medical Center
NCT05554146
Effects of Smoked Marijuana on Neuropathic Pain
Center for Medicinal Cannabis Research
NCT00254761
Virtual Reality Walking for Neuropathic Pain in Spinal Cord Injury
University of Alabama at Birmingham
NCT03735017
Tariquidar-ondansetron Combination in Neuropathic Pain
Washington University School of Medicine
NCT04603066
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
NeuraLace Medical
NCT05935956
Veteran Ear Acupuncture Pilot Project
Chillicothe VA Medical Center
NCT04208659
The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain
Virginia Commonwealth University
NCT01840345
Topical Naloxone to Diagnose Ocular Pain
Seema Capoor
NCT04454281
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 7 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Neuropathic Pain records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neuropathic Pain trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neuropathic Pain page
36 registered trials, 16 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 16 Neuropathic Pain trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- NeuraLace Medical sponsors the most Neuropathic Pain trials on record, review their full trial history before evaluating a specific study. See NeuraLace Medical's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neuropathic Pain condition card totals 36 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.